🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Rosacea Radiofrequency Microneedling

RecruitingNAAges 18 Years - anyAllUniversity of Miami
NCT06801717 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Male or female adult (\>18yo) subjects in general good health 2. Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea. 3. Subject is able to understand and sign informed consent 4. Subject is able to complete the study and comply with study procedures Exclusion Criteria: 1. Patients currently utilizing oxymetazoline or brimonidine. 2. Presence of dermatoses that might interfere with diagnosis as determined by a study investigator 3. Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum 4. Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment 5. History of poor wound healing or blood-clotting abnormality 6. History of keloid formation or hypertrophic scarring 7. Hypersensitivity or contraindication to local anesthetics as determined by the principal investigator or other medical professional. 8. Prisoners
💊

What it tests

  • KTP Laser Therapy
  • Radiofrequency microneedling
📍

Where

1 site
University of Miami Dermatology Miami Beach Clinic
Miami Beach, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy